Insider Trading & SAST disclosures for Kobo Biotech Ltd.
There were no Insider Trade disclosures made for Kobo Biotech Ltd.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Arch Pharmalabs Ltd in Kobo Biotech Ltd. where Disposal of 96,304
shares done
was reported to the exchange on May 12, 2015.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
12 May 2015 |
96,304 |
10,709,100
(47.59%)
|
0.43%
|
|
-
|
11 May 2015
11 May 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
04 May 2015 |
141,100 |
10,805,404
(48.02%)
|
0.63%
|
|
-
|
29 Apr 2015
29 Apr 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
24 Apr 2015 |
62,596 |
10,946,504
(48.65%)
|
0.28%
|
|
-
|
22 Apr 2015
22 Apr 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
04 Mar 2015 |
125,169 |
11,009,100
(48.93%)
|
0.56%
|
|
-
|
03 Mar 2015
03 Mar 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
02 Mar 2015 |
135,284 |
11,134,269
(49.49%)
|
0.60%
|
|
-
|
27 Feb 2015
27 Feb 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
26 Feb 2015 |
150,000 |
11,269,553
(50.09%)
|
0.67%
|
|
-
|
25 Feb 2015
25 Feb 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
24 Feb 2015 |
200,000 |
11,419,553
(50.75%)
|
0.89%
|
|
-
|
20 Feb 2015
23 Feb 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalasbs Ltd
|
Promoter |
Disposal |
20 Feb 2015 |
340,000 |
11,619,553
(51.64%)
|
1.51%
|
|
-
|
18 Feb 2015
19 Feb 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
18 Feb 2015 |
400,000 |
11,959,553
(53.16%)
|
1.78%
|
|
-
|
16 Feb 2015
16 Feb 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
16 Feb 2015 |
341,000 |
12,359,553
(54.93%)
|
1.52%
|
|
-
|
13 Feb 2015
13 Feb 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
12 Feb 2015 |
685,000 |
12,700,553
(56.45%)
|
3.04%
|
|
-
|
11 Feb 2015
11 Feb 2015 |
SAST (29(2)) |
- |
Market |
|
Arch Pharmalabs Ltd
|
Promoter |
Disposal |
10 Feb 2015 |
923,547 |
13,385,553
(59.49%)
|
4.11%
|
|
-
|
09 Feb 2015
09 Feb 2015 |
SAST (29(2)) |
- |
Market |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.